Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +86-18108235634 |
| E-mail: | cecilia@youngshechem.com |
| QQ: | 3203619841 |
| Skype: | Chat Now! |
| Address: | No.77, Tianmu Rd,New and Hi-tech Zone,Chengdu,China |
|
Chengdu Youngshe Chemical Co. Ltd is is a dynamic and progressive peptide and protein manufacturer in China. We are dedicated to be one of the most professional, efficient,and reliable partner for global customers on peptides and proteins. Youngshe has developed more than 2000 kinds of cosmetic peptides. catalog peptides, pharmaceutical peptides, proteins, etc.. And we are keeping developing new products and continuously marketing them for sale. Youngshe provide a one-stop service for peptide and protein. Youngshe will do whatever they can to save your time ,energy, money and make you a pleasant experience with us. Hi-new tech Zone campus in the suburb of Chengdu city provides Youngshe with a good infrastructure for both industrial-scale production of peptides and proteins. The pharmaceutical grade solid phase peptide synthesis in new campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales.
Our Mission
To make peptide and protein for global customers.
To combine innovation with excellence by developing and manufacturing quality peptide and protein accompanied by professional and friendly scientific support.
|
|
| Product Name | MF | CAS | Details |
|---|
| FAGLA | C15H21N3O4 | 26400-33-9 | Details |
| FALGPA | C23H32N4O7 | 78832-65-2 | Details |
| FA-KA-OH | C16H23N3O5 | 158016-07-0 | Details |
| FA-GLA-OH | C18H25N3O6 | 56186-50-6 | Details |
| FA-KL-OH | C19H29N3O5 | 158016-09-2 | Details |
| FA-PA-OH | C19H20N2O5 | 83803-17-2 | Details |
| FAPGG | C20H21N3O6 | 64967-39-1 | Details |
| FAPP | C25H24N2O5 | 83661-95-4 | Details |
| FA-FFR-OH | C31H36N6O6 | 86064-76-8 | Details |
| FA-FV-NH2 | C21H25N3O4 | 93936-27-7 | Details |
| Fibrinogen γ-Chain (117-133) | C84H147N25O27 | 160927-63-9 | Details |
| Fibrinogen γ-Chain (397-411) | C62H99N23O21 | 80755-86-8 | Details |
| Abz-RVKRGLA-nitro-Tyr-D | C54H84N18O16 | 174838-79-0 | Details |
| Boc-RRR-AMC | C38H62N14O8 | 136132-77-9 | Details |
| Furin Inhibitor II | C36H75N25O6 | 673202-67-0 | Details |
| Pyr-RTKR-AMC | C37H57N13O9 | 155575-02-3 | Details |
| Z-REKR-AMC | C41H58N12O10 | 201928-26-9 | Details |
| Galanin (human) | C139H210N42O43 | 119418-04-1 | Details |
| Galanin (mouse, rat) | C141H211N43O41 | 114547-31-8 | Details |
| Galanin (porcine) | C146H213N43O40 | 88813-36-9 | Details |
| Galanin (1-13)-Bradykinin (2-9) amide | C107H153N27O26 | 142846-71-7 | Details |
| Galanin (1-13)-Mastoparan | C133H222N34O32 | 177352-81-7 | Details |
| Galanin (1-13)-Neuropeptide Y (25-36) amide | C136H209N41O34 | 147138-51-0 | Details |
| Galanin (1-13)-Pro-Pro-(Ala-Leu-)2Ala amide | C94H145N23O24 | 143896-17-7 | Details |
| Galanin (1-13)-Spantide I | C138H199N35O30 | 143868-20-6 | Details |
| Galanin (1-13)-Substance P (5-11) amide | C104H151N25O26S | 138579-66-5 | Details |
| (Ala6,D-Trp8,L-alaninol15)-Galanin (1-15) | C81H114N20O18 | 184683-37-2 | Details |
| (D-Thr6,D-Trp89,L-alaninol15)-Galanin (1-15) | C84H117N21O18 | 150940-97-9 | Details |
| Galanin (1-16) (mouse, porcine, rat) | C78H116N20O21 | 125118-77-6 | Details |
| Galanin (1-19) (human) | C89H130N26O25 | 136005-51-1 | Details |
| Galanin-Like Peptide (human) | C292H451N83O84S | 245114-99-2 | Details |
| Galanin-Like Peptide (porcine) | C281H443N81O78 | 245114-96-9 | Details |
| Galanin-Like Peptide (rat) | C288H461N87O83S | 245114-97-0 | Details |
| Galanin Message Associated Peptide (1-41) amide | C206H326N56O64S1 | 132699-74-2 | Details |
| Galanin Message Associated Peptide (16-41) amide | C134H219N35O37S | 129541-35-1 | Details |
| Galanin Message Associated Peptide (25-41) amide | C90H143N21O22S | 132567-21-6 | Details |
| Galanin Message Associated Peptide (44-59) amide | C61H100N18O25 | 125455-59-6 | Details |
| Galnon, Fmoc-Cha-Lys-AMC | C40H46N4O6 | 475115-35-6 | Details |
| FA-Gly-Nva-NH2 | C14H19N3O4 | 67607-50-5 | Details |
| FAGPA | C18H19N3O4 | 26400-34-0 | Details |
| FA-GV-NH2 | C14H19N3O4 | 67607-49-2 | Details |
| Fmoc-GF-OH | C26H24N2O5 | 117370-45-3 | Details |
| Fmoc-GP-Hyp-OH | C27H29N3O7 | 185213-75-6 | Details |
| Fmoc-GV-OH | C22H24N2O5 | 86895-14-9 | Details |
| Fmoc-Lys(Boc)-Leu-OH | C32H43N3O7 | 250695-63-7 | Details |
| Fmoc-FR-OH | C30H33N5O5 | 250695-64-8 | Details |
| Fmoc-FF-OH | C33H30N2O5 | 84889-09-8 | Details |
| Fmoc-Phe-Ser(tBu)-OH | C31H34N2O6 | 157675-78-0 | Details |
| Fmoc-PF-OH | C29H28N2O5 | 120943-07-9 | Details |
| Fmoc-PPP-OH | C30H33N3O6 | 134303-96-1 | Details |
| Fmoc-PPPP-OH | C35H40N4O7 | 454693-96-0 | Details |
| Fmoc-PPPPP-OH | C40H47N5O8 | 454693-94-8 | Details |
| Fmoc-WP-OH | C31H29N3O5 | 251316-94-6 | Details |
| Fmoc-YA-OH | C27H26N2O6 | 220886-40-8 | Details |
| ACEP-1 | C57H85N21O15 | 127122-98-9 | Details |
| Ac-F-Nle-RF-NH2 | C32H46N8O5 | 83903-28-0 | Details |
| AF-1 | C45H69N13O10 | 130092-56-7 | Details |
| AF-2 | C47H70N14O10 | 146269-94-5 | Details |
| H-NRNFLRF-NH2 | C44H68N16O9 | 149471-12-5 | Details |
| Neuropeptide DF2 | C44H67N15O10 | 149471-11-4 | Details |
| LSSFVRIamide | C38H65N11O9 | 148054-14-2 | Details |
| MRF | C20H32N6O4S | 67368-25-6 | Details |
| H-Nle-RF-NH2 | C21H35N7O3 | 104809-29-2 | Details |
| FLRFamide | C30H44N8O4 | 80690-77-3 | Details |
| Molluscan Cardioexcitatory Neuropeptide | C29H42N8O4S | 152165-14-5 | Details |
| (D-Phe1)-FMRFamide | C29H42N8O4S | 84313-42-8 | Details |
| (D-Met2)-FMRFamide | C29H42N8O4S | 84313-43-9 | Details |
| (D-Phe4)-FMRFamide | C29H42N8O4S | 84413-35-4 | Details |
| (D-Arg3)-FMRFamide | C29H42N8O4S | 84313-44-0 | Details |
| Schisto FLRFamide | C59H86N16O14 | 121801-61-4 | Details |
| FMRF-Like Peptide | C44H61N11O10 | 98495-35-3 | Details |
| FMRF-Like Peptide F1 | C48H75N17O11 | 113611-68-0 | Details |
| W-Nle-RF-NH2 | C32H45N9O4 | 83903-33-7 | Details |
| YFMRF -NH2 | C38H51N9O6S | 99414-63-8 | Details |
| Neuropeptide AF (human) | C90H132N26O25 | 192387-38-5 | Details |
| Neuropeptide SF (human) | C65H94N18O15 | 192387-39-6 | Details |
| Neuropeptide VF (124-131) (human) | C45H72N14O10 | 311309-27-0 | Details |
| Neuropeptide VF Precursor (108-125) amide (rat) | C88H134N26O25S2 | 420088-80-8 | Details |
| FA-AR-OH | C16H23N5O5 | 76079-06-6 | Details |
| FA-AK-OH | C16H23N3O5 | 76079-03-3 | Details |
| FA-AF-NH2 | C19H21N3O4 | 29268-00-6 | Details |
| FA-RL-OH | C19H29N5O5 | 158016-08-1 | Details |
| FA-DA-OH | C14H16N2O7 | 196791-00-1 | Details |
| FA-GL-OH | C15H20N2O5 | 69654-89-3 | Details |
| N-Me-GRGDSP | C23H39N9O10 | 133525-11-8 | Details |
| YRGDS | C24H36N8O10 | 134282-68-1 | Details |
| RFDS | C22H33N7O8 | 102567-19-1 | Details |
| SDGRG | C17H30N8O9 | 108608-63-5 | Details |
| Fmoc-AA-OH | C21H22N2O5 | 87512-31-0 | Details |
| Fmoc-GGG-OH | C21H21N3O6 | 170941-79-4 | Details |
| Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human) | C43H53N7O9S | 78700-57-9 | Details |
| Gastric Inhibitory Polypeptide (human) | C226H338N60O66S | 100040-31-1 | Details |
| Gastric Inhibitory Polypeptide (porcine) | C225H342N60O66S1 | 11063-17-5 | Details |
| Gastric Inhibitory Polypeptide (1-30) amide (porcine) | C162H245N41O47S | 134846-93-8 | Details |
| Gastrin I (1-14) (human) | C79H100N16O27 | 100940-57-6 | Details |
| Big Gastrin I (human), Gastrin-34 | C176H251N43O53S1 | 60675-77-6 | Details |
| Gastrin I (human), Gastrin-17 (human) | C97H124N20O31S | 10047-33-3 | Details |
| Gastrin I (human) (sulfated), Gastrin II | C97H124N20O34S2 | 19361-51-4 | Details |
| (Leu15)-Gastrin-17 I (human) | C98H126N20O31 | 39024-57-2 | Details |
| Gastric Inhibitory Polypeptide (6-30) amide (human) | C139H209N35O38S | 1139691-72-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 | ||||